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Introduction: Indications and results of salvage surgery in medi-
astinal tumors are still unclear. This study analyzes a single-
center experience to assess its mortality, morbidity, and long-
term results.
Methods: Mediastinal salvage surgery (MSS) was defined as sur-
gical resection of persistent or recurrent primary mediastinal tumors
after previous local treatments with curative intent or exclusive
chemotherapy in case of bulky tumors. Clinical data of patients
undergoing MSS between 1998 and 2005 were analyzed. Overall
and disease-specific long-term survival was calculated.
Results: Twenty-one patients (15 men and 6 women, mean age 41
years) underwent MSS. Eleven patients suffered from thymic tumors
(eight thymomas, three thymic carcinoma) whereas 10 patients
suffered from nonthymic tumors (one lung adenocarcinoma 
thymoma, two mediastinal monophasic sinovial sarcoma, one me-
diastinal neuroendocrine tumor, one mediastinal teratoblastoma, one
mediastinal disgerminoma, one Hodgkin’s lymphoma, one medias-
tinal atypic carcinoid, two medullary thyroid carcinoma). MSS
required extended vascular resection in 10 cases and cardiopulmo-
nary bypass in one case. Median operation time was 215 minutes
(range 140–720). One postoperative death and four major compli-
cations were recorded (overall mortality 4.7%, morbidity 19.0%).
With a median follow-up of 30.6 months, overall 1-, 3-, and 5-year
Kaplan-Meier survival was 89.7, 71.2, and 56.6%, respectively.
Thymic neoplasms had a better prognosis (1-, 3-, and 5-year survival
was 100, 87.5, 87.5%, respectively) when compared with others (1-,
3-, and 5-year survival was 77.8, 53.3, 26.7%, respectively—logrank
p  0.0128).
Conclusions: MSS can offer a chance of curative treatment in
selected patients with an acceptable morbidity and mortality.
Thymic tumors obtain the best results in term of long-term
survival.
Key Words: Mediastinum, Salvage surgery, Mediastinal neo-
plasms.
(J Thorac Oncol. 2008;3: 53–58)
Mediastinal malignancies are a heterogeneous group ofdiseases most of which are suitable for curative surgical
resection, such as thymic tumors, nonseminomatous germ
cell tumors (nonresponders after chemotherapy), and mesen-
chymal malignancies. In the case of extensive disease infil-
trating contiguous vascular, cardiac or pulmonary structures,
or in the case of recurrent mediastinal tumors after previous
surgical resection, patients are often considered inoperable.
Afterward, patients usually receive nonsurgical treatments
with curative intent and some of them with persistent disease
and without any other potential treatment are referred to
thoracic surgeons.
In some instances, the indication for an extended “sal-
vage” procedure can be discussed in young and fit patients.
This salvage surgery often requires long operating time,
extended vascular or pulmonary resections, and it results in
higher postoperative morbidity. This increased risk is not
well defined because the impact of mediastinal salvage sur-
gery (MSS) is masked by the presence of standard resections
in reported surgical series of thymic tumors, mesenchymal
and germ cell malignancies.1
The aim of this study was to review our experience in
the subset of mediastinal malignancies requiring salvage
extended mediastinal resection to assess postoperative mor-
bidity and mortality, with the secondary aim of searching of
long-term survival predictors after radical resection.
PATIENTS AND METHODS
MSS was defined as surgical resection of persistent or
recurrent primary mediastinal tumors after previous local
treatments with curative intent or exclusive chemotherapy in
case of bulky tumors. Patients affected by mediastinal me-
tastases from nonthoracic primary tumors were not included
in the present study.
In all cases, surgery was planned to obtain complete
tumor removal by radical mediastinectomy (removal of all
mediastinal tissues from the upper thymic lobes to diaphrag-
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matic pericardial fat pad and from the left to the right phrenic
nerves) and resection of all the involved contiguous anatomic
structures.
We retrospectively reviewed data base information on
patients who had undergone MSS to evaluate postoperative
mortality (defined as any death occurring during hospital stay
TABLE 1. Clinicopathologic and Surgical Features of Patients
Case
No. Age/Sex Diagnosis Previous Treatment Surgery CPB Approach
1 38/M Lung adenocarcinoma 
SVC infiltration 
thymoma
CT Right upper lobectomy  resection of
thymoma  SVC reconstruction
No Sternotomy  TMA 
cervicotomy
2 21/F Mediastinal monophasic
sinovial sarcoma
Nonradical surgery  CT Right pneumonectomy No Right hemiclamshell
3 32/F Malignant thymoma RT Left pleuropneumonectomy  resection
of thymoma
No Left hemiclamshell
4 29/M Malignant thymoma CT Resection of thymoma (pericardiectomy
left phrenic nerve resection  left
upper lobe wedge resection)
No Sternotomy
5 24/M Malignant thymoma Nonradical surgery  CT Completion resection of thymoma  right
pleurectomy  right lung
bimetastasectomy
No Right hemiclamshell
6 29/F Mediastinal monophasic
sinovial sarcoma
Nonradical surgery  CT Tumor resection  left upper lobectomy 
phrenic and recurrent nerves
resection  left brachiocepahlic vein
reconstruction
No Left hemiclamshell
7 61/F Thymic carcinoma RT Thymectomy  left common carotid
resection/reconstruction  left
hemithyroidectomy  left giugular vein
resection
No TMA
8 13/F Mediastinal mesenchymal
neuroendocrine tumor
CT Explorative Thoracotomy (complete
cardiac infiltration)
No Left hemiclamshell
9 44/M Thymic carcinoid CT Thymectomy  pericardiectomy 
phrenic nerve resection
No Sternotomy
10 30/M Mediastinal teratoblastoma CT Tumour resection  right upper lobe
wedge resection  pericardiectomy 
left and right brachiocephalic veins
resection/reconstruction
No Clamshell
11 55/M Malignant thymoma CT Thymectomy  SVC
resection/reconstruction
No Sternotomy
12 41/M Disgerminoma CT Tumour resection  middle lobe and left
upper lobe wedge resection, pericardial
and right phrenic nerve resection
No Sternotomy
13 45/M Malignant thymoma CT Resection of thymoma  SVC resection
and reconstruction
No Sternotomy
14 38/M Malignant thymoma RT Resection of thymoma No Left hemiclamshell
15 47/M Hodgkin’s lymphoma CT Tumor resection No Sternotomy
16 73/M Mediastinal atypical
carcinoid
CT Tumor resection No TMA  sternotomy
17 47/M Thymic carcinoma CT Tumor resection  left upper lobe
resection  left brachiocephalic vein
resection/reconstruction
No Left hemiclamshell
18 54/M Medullary thyroid
carcinoma
CT  radio metabolic
therapy
Explorative cervico sternotomy No Cervicosternotomy 
manubriotomy









Thymectomy  brachiocephalic artery
reconstruction  omentoplasty
No Cervicosternotomy
21 50/F Malignant thymoma CT Resection of thymoma  SVC resection
and reconstruction  right atrium
resection
Yes TMA  sternotomy
CT, chemotherapy; RT, radiotherapy; TMA, transmanubrial approach.
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or within 30 days after surgery), morbidity (pulmonary,
cardiac, surgical, and others), and long-term survival.
We analyzed the impact of eight variables (age, sex,
preoperative forced expiratory volume in 1 second, previous
treatments, associated lung or vascular resections, operating
time, use of cardiopulmonary bypass [CPB]) on postoperative
morbidity and mortality. Comparisons were made using the
Student t test for continuous variables and the 2 test for
categorical variables; p values were considered significant
when 0.05.
Follow-up was obtained by telephonic contact in Jan-
uary 2006. Overall 5-year survival was calculated by the
Kaplan-Meier method; comparisons between groups (thymic
tumors versus others) were performed by logrank test.
RESULTS
From January 1, 1998 to January 1, 2005, we performed
21 mediastinal salvage procedures. Patient characteristics are
shown in Table 1. Eleven patients suffered from thymic tumors
(eight thymomas, three thymic carcinoma) whereas 10 patients
suffered from nonthymic tumors (one lung adenocarcinoma 
thymoma, two mediastinal monophasic sinovial sarcoma, one
mediastinal neuroendocrine tumor, one mediastinal teratoblas-
toma, one mediastinal disgerminoma, one Hodgkin’s lym-
phoma, one mediastinal atypic carcinoid, two medullary thyroid
carcinoma).
Surgical approaches were median sternotomy in six
cases; sternotomy and transmanubrial approach (TMA) in
two cases, right hemiclamshell in two cases, left hemiclam-
shell in six cases, TMA alone in one case, clamshell in one
case, combined approaches in three cases.
Median operation time was 215 minutes (range 140–
720). We performed eight extended venous vascular resec-
tions (four superior vena cava resections and four brachioce-
phalic veins resections), two arterial resections (one carotid
artery resection and one brachiocephalic artery resection),
one operation (4.7%) required CPB for cardiac infiltration.
Together with mediastinectomy, we performed anatomic pul-
monary resections in five cases (two were lobectomies, one
pneumonectomy, and two pleuropneumonectomies).
No intraoperative deaths were recorded, one postoper-
ative death after right upper lobectomy  thymomectomy 
superior vena cava reconstruction was recorded (overall 30
days mortality: 4.7%,), 4 major complications were recorded
(overall morbidity 19.0%): two vascular prosthesis thrombo-
sis (9.5%), one cardiac acute myocardial infarction (4.7%),
and one bleeding requiring redo thoracotomy 4.7%. We had
two explorative thoracotomies (9.5%). Mean postoperative
intensive care unit stay was 11 days (range, 0–77days).
Univariate analyses showed no significant association
between morbidity or mortality with age, sex, forced expira-
tory volume in 1 second, and previous treatments; only
FIGURE 1. A, Overall 5 years Kaplan-Meier survival curve
(NE: not evaluable); upper limit of confidence interval not
assessable. B, Comparison between 5 years Kaplan-Meier
survival curve of thymic and nonthymic groups.
TABLE 2. Proportional Hazard Model (Cox Regression)
Overall Survival Risk Factors—Reduced Model
Hazard Ratio (95% CI) Significance Level (p)
Others vs. thymus 10.61 (2.09–53.88) 0.0044
Lung resection 3.73 (0.79–17.61) 0.0962
Vascular resection 2.63 (0.51–13.69) 0.2482
TABLE 3. Survival by Group at 1, 3, and 5 Years
(Kaplan-Meier Estimates)
Time
(yr) Group Survival  SE
Patients
at Risk
1 Thymus 100% 9
Others 77.8%  13.9% 7
Overall 89.7%  6.9% 16
3 Thymus 87.5%  11.7% 7
Others 53.3%  17.3% 4
Overall 71.2%  11.0% 11
5 Thymus 87.5%  11.7% 5
Others 26.7%  15.9% 1
Overall 56.6%  12.8% 5
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associated vascular and pulmonary resections showed a
slightly increased risk; however, not statistically significant
(Table 2).
Overall 1-, 3-, and 5-year Kaplan-Meier survival was
89.7, 71.2, and 56.6%, respectively. Thymic neoplasms had a
better prognosis (1-, 3-, and 5-year actuarial survival was
100, 87.5, 87.5%, respectively) when compared with others
(1-, 3-, and 5-year actuarial survival was 77.8, 53.3, 26.7%,
respectively—log rank p  0.0128) (Figures 1A, B and Table
3). None of the considered variables affected long-term
survival.
DISCUSSION
In surgical oncology, complete resection is necessary to
prolong survival, offering the patients the most effective
therapeutic option.1,2 Successful complete resection in ex-
tremely large mediastinal malignancies, which have been
previously treated with curative intent, is an oncological and
technical challenge.
Results from our series confirmed that the judgment of
inoperability can be reevaluated in selected cases given that
they may benefit from extensive surgery, with an acceptable
surgical mortality and postoperative morbidity rate. This
FIGURE 2. Intraoperative views of
“second-line” mediastinal resections:
single surgeon personal series. A, CT
scan disclosing huge thymic carci-
noma after chemotherapy. B, Intraop-
erative view of the huge thymic carci-
noma resection.
FIGURE 3. Vascular reconstruction after thymic resection
(left innominate vein reconstructed by polytetrafluoroethyl-
ene (PTFE) prosthesis).
FIGURE 4. Atrial resection and reconstruction by polytetra-
fluoroethylene (PTFE) prosthesis after invasive thymoma re-
section.
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information was already available for thymic tumors3,4 (Fig-
ures 2–4); as far as we know, our study is the first to also
consider salvage surgery for nonthymic malignant neo-
plasms. On the one hand, the decision to analyze all the types
of mediastinal malignancies together creates a heterogeneous
population, which represents a limitation in this study. On the
other hand, it permits a comparison of thymic and nonthymic
diseases surgically treated homogeneously at the same insti-
tution. Results demonstrate that in the case of radical resec-
tion, nonthymic tumors have an acceptable long-term sur-
vival rate suggesting that they should not be excluded from
salvage surgery when feasible. Our results confirmed that
thymic neoplasms have the best long-term survival rate after
radical resection (87.5% at 5 years), representing the ideal
condition for successful salvage surgery. None of the selected
variables statistically influenced postoperative morbidity rate;
probably the small number of patients reported in the present
series conditioned statistical evaluation of the results.
MSS very often requires an alternative approach other
than sternotomy because complete exposure is crucial for the
efficacy of extensive surgery. We have already described the
combination of the TMA and sternotomy to access the me-
diastinum in the case of huge mass.5 Marta et al. recently
described inverse T incision for the upper mediastinum.6
Even with the best exposure, the risk involved in
nonradical resection must be considered, for functional and
oncological reasons. From the functional point of view, the
limit is represented by diseases involving both phrenic
nerves, which cannot be resected without causing bilateral
diaphragmatic palsy and consequent respiratory failure; it can
lead to a nonradical resection, as it once occurred in our series
(case no.18). From the oncological point of view, unexpected
or underestimated infiltration of mediastinal structures can
represent another cause of explorative procedure. Cardiac
infiltration is not per se an absolute contraindication to
resection, as myocardial resection is feasible by the use of
CPB.4,9,10 CPB use in oncology is still controversial because
of the risk of systemic tumor dissemination caused by suction
of blood, which is then returned to the circuit system, result-
ing in a generalization of a thus far localized disease.7,8,12 The
use of a passive shunt or of a femorofemoral heparinized
extracorporeal membrane oxygenator has been proposed to
reduce the risk of neoplastic cell dissemination occurring
mainly during great vessels resection.2,11 During the study
period, we used only conventional extracorporeal circulation
in 1 patient in the present series because the above-mentioned
risk still remains theoretical and in our experience with CPB
in thoracic oncology, we did not record a higher risk of
distant metastases (Figure 5).
In conclusion, according to our present results, second-
line MSS may represent the sole effective therapy for non-
responders to other curative treatments when patients were
considered ineligible to surgery at any time of the history of
their disease. In this situation, salvage surgery offers a satis-
factory long-term survival with an acceptable surgical mor-
tality and postoperative morbidity. Thymic neoplasms repre-
sent mediastinal malignancies with the best results after
radical salvage resection. In nonthymic tumors, indication to
salvage surgery should be discussed case by case, considering
that long-term survival in completely resected patients is not
negligible (26.7% at 5 years).
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